Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Short-term Investments (2021 - 2025)

Historic Short-term Investments for Abvc Biopharma (ABVC) over the last 5 years, with Q3 2025 value amounting to $661843.0.

  • Abvc Biopharma's Short-term Investments rose 463.44% to $661843.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $661843.0, marking a year-over-year increase of 463.44%. This contributed to the annual value of $615433.0 for FY2024, which is 627.33% down from last year.
  • As of Q3 2025, Abvc Biopharma's Short-term Investments stood at $661843.0, which was up 463.44% from $688075.0 recorded in Q2 2025.
  • Over the past 5 years, Abvc Biopharma's Short-term Investments peaked at $688075.0 during Q2 2025, and registered a low of $68521.0 during Q3 2023.
  • In the last 5 years, Abvc Biopharma's Short-term Investments had a median value of $111320.0 in 2021 and averaged $346078.2.
  • Per our database at Business Quant, Abvc Biopharma's Short-term Investments crashed by 3030.63% in 2022 and then soared by 82311.7% in 2024.
  • Over the past 5 years, Abvc Biopharma's Short-term Investments (Quarter) stood at $108147.0 in 2021, then fell by 29.91% to $75797.0 in 2022, then surged by 766.29% to $656625.0 in 2023, then dropped by 6.27% to $615433.0 in 2024, then grew by 7.54% to $661843.0 in 2025.
  • Its Short-term Investments stands at $661843.0 for Q3 2025, versus $688075.0 for Q2 2025 and $607362.0 for Q1 2025.